HIV/AIDS Clinical Trials

Showing 41-60 of 3,256 trials

Implementing Depression and Adherence Treatment

NCT07032363

The goal of this clinical trial is to compare a core set and enhanced set of implementation strategies in increasing the reach of evidence-based treatments to patients with HIV and depression. The main questions it aims to answer are: What proportion of patients start an evidence-based treatment for depression (reach)? What percentage of patients show clinical improvement in depression and what percentage attain viral undetectability within one year (effectiveness)? Researchers will compare high and low reach clinics to further inform tailored implementation strategies for uptake and maintenance. Clinics will be randomized into one of two study arms: core versus enhanced strategies. In both arms, core strategies will be utilized. Enhanced clinics will also receive more resource-intensive training.

DepressionHIVAdherence, Treatment+1 more

University of Miami10 participantsStarted Apr 2026

Miami, Florida, United States • Boston, Massachusetts, United States • Cape Town, South Africa

Not Yet RecruitingPhase 1

A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection

NCT06987318

The purpose of this study is to evaluate the safety, tolerability, and efficacy of combination broadly neutralizing antibodies (bNAbs), to induce HIV-1 control during analytic treatment interruption (ATI).

HIV-1-infection

National Institute of Allergy and Infectious Diseases (NIAID)40 participantsStarted Jun 2026

Birmingham, Alabama, United States • San Diego, California, United States • Aurora, Colorado, United States +10 more locations

Implementing Depression and Adherence Treatment

A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection

Related Searches

Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients

Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)

Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury

Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW

Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS

Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Tonsillectomy

Extended Follow-Up of the ISS T-003 Trial Volunteers (ISS T-003 EF-UP2020)

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older

LetSync: Pilot Test of Mobile Health (mHealth) Intervention

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

A Pilot Project for PLWH Aged 65-75: Preventing the Development of Frailty

Study of the Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage

Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program

Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs